{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:58:06Z","timestamp":1792634286935,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.antiviral.2013.07.009","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T16:18:02Z","timestamp":1374769082000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Antiviral activity of angelicin against gammaherpesviruses"],"prefix":"10.1016","volume":"100","author":[{"given":"Hye-Jeong","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Gyeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ah","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Ri","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.07.009_b0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11262-008-0325-y","article-title":"Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments","volume":"38","author":"Arav-Boger","year":"2009","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2013.07.009_b0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ecam\/nem139","article-title":"Fetal hemoglobin inducers from the natural world: a novel approach for identification of drugs for the treatment of {beta}-thalassemia and sickle-cell anemia","volume":"6","author":"Bianchi","year":"2009","journal-title":"Evidence-Based Complementary and Alternative Medicine: eCAM"},{"issue":"3","key":"10.1016\/j.antiviral.2013.07.009_b0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0163-7258(91)90031-G","article-title":"Angelicins, angular analogs of psoralens: chemistry, photochemical, photobiological and phototherapeutic properties","volume":"52","author":"Bordin","year":"1991","journal-title":"Pharmacology & Therapeutics"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2013.07.009_b0020","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1111\/j.1601-0825.1997.tb00343.x","article-title":"Etiology of AIDS-related Kaposi\u2019s sarcoma and lymphoma","volume":"3","author":"Boshoff","year":"1997","journal-title":"Oral Diseases"},{"key":"10.1016\/j.antiviral.2013.07.009_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/135965350501000609","article-title":"Prostratin and bortezomib are novel inducers of latent Kaposi\u2019s sarcoma-associated herpesvirus","volume":"10","author":"Brown","year":"2005","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.antiviral.2013.07.009_b0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1042\/BST0380050","article-title":"Antiviral activity of resveratrol","volume":"38","author":"Campagna","year":"2010","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.antiviral.2013.07.009_b0035","first-page":"54","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi\u2019s sarcoma, primary effusion lymphoma, and multicentric Castleman\u2019s disease","volume":"14","author":"Cesarman","year":"1997","journal-title":"Seminars in Diagnostic Pathology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0040","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00705-008-0144-4","article-title":"Lytic induction of Kaposi\u2019s sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening","volume":"153","author":"Cho","year":"2008","journal-title":"Archves of Virology"},{"issue":"4","key":"10.1016\/j.antiviral.2013.07.009_b0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1751-1097.1979.tb07769.x","article-title":"Herpes virus production in monkey kidney and human skin cells treated with angelicin or 8-methoxypsoralen plus 365nm light","volume":"29","author":"Coppey","year":"1979","journal-title":"Photochemstry and Photobiology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0050","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/JVI.76.10.5208-5219.2002","article-title":"Transcriptional downregulation of ORF50\/Rta by methotrexate inhibits the switch of Kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus 8 from latency to lytic replication","volume":"76","author":"Curreli","year":"2002","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/j.antiviral.2013.07.009_b0055","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/JVI.79.9.5875-5879.2005","article-title":"Induction of lytic Epstein\u2013Barr virus (EBV) infection by synergistic action ofrituximab and dexamethasone renders EBV-positive lymphoma cells moresusceptible to ganciclovir cytotoxicity in vitro and in vivo","volume":"79","author":"Daibata","year":"2005","journal-title":"Journal of Virology"},{"issue":"10","key":"10.1016\/j.antiviral.2013.07.009_b0060","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1541-7786.MCR-11-0145","article-title":"Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt\u2019s lymphoma cells depending on viral latency program","volume":"9","author":"De Leo","year":"2011","journal-title":"Molecular Cancer Research"},{"issue":"2","key":"10.1016\/j.antiviral.2013.07.009_b0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2012.09.003","article-title":"Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt\u2019s lymphoma cells by affecting multiple molecular targets","volume":"96","author":"De Leo","year":"2012","journal-title":"Antiviral Research"},{"key":"10.1016\/j.antiviral.2013.07.009_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-3542(99)00042-X","article-title":"Resveratrol inhibition of herpes simplex virus replication","volume":"43","author":"Docherty","year":"1999","journal-title":"Antiviral Research"},{"issue":"3","key":"10.1016\/j.antiviral.2013.07.009_b0075","doi-asserted-by":"crossref","first-page":"e33364","DOI":"10.1371\/journal.pone.0033364","article-title":"Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1","volume":"7","author":"Dyson","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.antiviral.2013.07.009_b0080","doi-asserted-by":"crossref","first-page":"e51306","DOI":"10.1371\/journal.pone.0051306","article-title":"Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells","volume":"7","author":"Espinoza","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.07.009_b0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2004.03.002","article-title":"3,4\u2032,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling","volume":"63","author":"Evers","year":"2004","journal-title":"Antiviral Research"},{"key":"10.1016\/j.antiviral.2013.07.009_b0090","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein\u2013Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"Journal of Virology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/092986707779313318","article-title":"Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia","volume":"14","author":"Gambari","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.antiviral.2013.07.009_b0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/infdis\/173.6.1477","article-title":"Use of antiherpes drugs and the risk of Kaposi\u2019s sarcoma: data from the Multicenter AIDS Cohort Study","volume":"173","author":"Glesby","year":"1996","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.antiviral.2013.07.009_b0105","first-page":"129","article-title":"Inhibition of cytochrome P450 by furocoumarins in grapefruit juice and herbal medicines","volume":"25","author":"Guo","year":"2004","journal-title":"Acta Pharmacologica Sinca"},{"issue":"2","key":"10.1016\/j.antiviral.2013.07.009_b0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1099\/0022-1317-40-2-345","article-title":"Photochemical inactivation of DNA and RNA viruses by psoralen derivatives","volume":"40","author":"Hanson","year":"1978","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0110","first-page":"119","article-title":"Determination of viral infectivity: HSV, VZV, and CMV","volume":"24","author":"Harper","year":"2000","journal-title":"Methods in Molecular Medicine"},{"issue":"24","key":"10.1016\/j.antiviral.2013.07.009_b0225","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.1128\/JVI.01152-08","article-title":"Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo","volume":"82","author":"Hwang","year":"2008","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2013.07.009_b0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2011.11.012","article-title":"Persistent infection of a gammaherpesvirus in the central nervous system","volume":"423","author":"Kang","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12185-009-0422-2","article-title":"Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs","volume":"90","author":"Lampronti","year":"2009","journal-title":"International Journal of Hematology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0120","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1128\/JVI.00001-07","article-title":"The ORF49 protein of murine gammaherpesvirus 68 cooperates with RTA in regulating virus replication","volume":"81","author":"Lee","year":"2007","journal-title":"Journal of Virology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0125","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1248\/bpb.31.2018","article-title":"Inhibition of the epstein\u2013barr virus lytic cycle by andrographolide","volume":"31","author":"Lin","year":"2008","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.antiviral.2013.07.009_b0130","first-page":"329","article-title":"Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel","volume":"127","author":"Martin","year":"1999","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0135","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.fct.2011.11.023","article-title":"Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity","volume":"50","author":"Messer","year":"2012","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0140","first-page":"1101","article-title":"Anti-herpesvirus treatment and risk of Kaposi\u2019s sarcoma in HIV infection. Royal Free\/Chelsea and Westminster Hospitals Collaborative Group","volume":"10","author":"Mocroft","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.07.009_b0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002030-199602000-00007","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus infection prior to onset of Kaposi\u2019s sarcoma","volume":"10","author":"Moore","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.07.009_b0150","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2013.07.009_b0155","doi-asserted-by":"crossref","first-page":"e14535","DOI":"10.1371\/journal.pone.0014535","article-title":"Rapamycin blocks production of KSHV\/HHV8: insights into the anti-tumor activity of an immunosuppressant drug","volume":"6","author":"Nichols","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.07.009_b0160","article-title":"The family herpesviridae: a brief introduction","volume":"vol. 2","author":"Pellett","year":"2007"},{"key":"10.1016\/j.antiviral.2013.07.009_b0165","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1128\/AAC.00417-09","article-title":"Inhibition of herpesvirus replication by 5-substituted 4\u2032-thiopyrimidine nucleosides","volume":"53","author":"Prichard","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.antiviral.2013.07.009_b0170","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/tx9002287","article-title":"Relative photomutagenicity of furocoumarins and limettin in the hypoxanthine phsophoribosyl transferase assay in V79 cells","volume":"22","author":"Raquet","year":"2009","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0235","unstructured":"Rickinson, A.B., Kieff, E., 2007. Epstein-barr virus. In: Fields Virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Hagerstown, MD."},{"key":"10.1016\/j.antiviral.2013.07.009_b0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0966-842X(98)01306-7","article-title":"Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis","volume":"6","author":"Simas","year":"1998","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0180","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.0404521102","article-title":"Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis","volume":"102","author":"Song","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.antiviral.2013.07.009_b0185","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1749-6632.2009.04894.x","article-title":"Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarinderivatives","volume":"1171","author":"Viola","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.antiviral.2013.07.009_b0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0952-7915(99)80063-6","article-title":"Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection","volume":"11","author":"Virgin","year":"1999","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0273-2300(91)90029-U","article-title":"Dietary exposure to furocoumarins","volume":"14","author":"Wagstaff","year":"1991","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.antiviral.2013.07.009_b0200","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1128\/JVI.75.19.9262-9273.2001","article-title":"Function of Rta is essential for lytic replication of murine gammaherpesvirus 68","volume":"75","author":"Wu","year":"2001","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/j.antiviral.2013.07.009_b0205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/jm901570x","article-title":"Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicinderivatives","volume":"53","author":"Yeh","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.antiviral.2013.07.009_b0210","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.3390\/molecules15107115","article-title":"Inhibitory effects of resveratrol on the Epstein\u2013Barr virus lytic cycle","volume":"15","author":"Yiu","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2013.07.009_b0215","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1371\/journal.ppat.0030044","article-title":"Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus","volume":"3","author":"Yu","year":"2007","journal-title":"PLoS Pathogens"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T12:15:39Z","timestamp":1688386539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0166354213001964"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.07.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of angelicin against gammaherpesviruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}